LinusBio

📍 New York, United States🗓 Founded 2020👥 5 employees💰 Last funded Mar 2022
Biotechnology Research🌐 linusbio.com
Website LinkedIn
Linus Biotechnology is a patient-centric, breakthrough science, precision exposome medicine company. Our program pipeline comprises precision exposome medicine biomarkers and target discovery across disease domains for which historically no molecular endpoints have been available in medical practice or for clinical trials, including CNS (autism spectrum disorder, amyotrophic lateral sclerosis), gastroenterology (inflammatory bowel disease), renal disease and oncology.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in LinusBio?
LinusBio has 1 investors on record on gritt.io, including 1 early-stage backers.
When did LinusBio last raise funding?
The most recent investment in LinusBio recorded on gritt.io was in March 2022.
When was LinusBio founded?
LinusBio was founded in 2020.
What industry is LinusBio in?
LinusBio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is LinusBio based?
LinusBio is headquartered in New York, United States.